mesalamine has been researched along with Gastric Diseases in 6 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the present study was to determine whether the split products of sulfasalazine, sulfapyridine, and 5-aminosalicylic acid can ameliorate ischemia/reperfusion-induced injury to the gastric mucosa." | 3.67 | 5-Aminosalicylic acid protects against ischemia/reperfusion-induced gastric bleeding in the rat. ( Grisham, MB; Kvietys, PR; Manci, EA; Smith, SM, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaaban, H | 1 |
| Maroules, M | 1 |
| Kim, JH | 1 |
| Moon, W | 1 |
| Park, SJ | 1 |
| Park, MI | 1 |
| Kim, SE | 1 |
| Ku, KH | 1 |
| Song, SE | 1 |
| Chang, HK | 1 |
| Tseng, TC | 1 |
| Chang, YT | 1 |
| Wong, JM | 1 |
| Nagamata, H | 1 |
| Torii, A | 1 |
| Izumi, M | 1 |
| Anami, M | 1 |
| Yamashita, N | 1 |
| Inadama, E | 1 |
| Toda, G | 1 |
| Miehsler, W | 1 |
| Püspök, A | 1 |
| Oberhuber, T | 1 |
| Vogelsang, H | 1 |
| Kvietys, PR | 1 |
| Smith, SM | 1 |
| Grisham, MB | 1 |
| Manci, EA | 1 |
1 review available for mesalamine and Gastric Diseases
| Article | Year |
|---|---|
[A case of Crohn's disease that shows the improvement of the gastric disorder by the administration of mesalazine powder].
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Male; M | 2000 |
5 other studies available for mesalamine and Gastric Diseases
| Article | Year |
|---|---|
A rare case of gastric Crohn's disease associated with immune thrombocytopenic purpura.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Male; Mesalamine; Middle Aged; Purpu | 2013 |
Protein-losing gastropathy caused by mesalamine in a patient with ulcerative colitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Endoscopy, Gastrointestinal; Female; H | 2014 |
Education and imaging. Gastrointestinal: gastric Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Colonoscopy; Crohn Disease; Diagnosis, Differential | 2007 |
Impact of different therapeutic regimens on the outcome of patients with Crohn's disease of the upper gastrointestinal tract.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Crohn Disease; Data Interpretatio | 2001 |
5-Aminosalicylic acid protects against ischemia/reperfusion-induced gastric bleeding in the rat.
Topics: Aminosalicylic Acids; Animals; Dimethyl Sulfoxide; Gastrointestinal Hemorrhage; Hydroxides; Hydroxyl | 1988 |